COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.


Clinical Trial in Mexico – Phase III trial of DNA Covid vaccine.

The trial will evaluate the efficacy of a two-dose regimen of INO-4800 administered one month apart in adult subjects.


First-in-Human – T-Cell Therapy Clinical Trial.

TACTIC-2 marks first in-human use of TAC-T cell therapy.


Clinical Trials – New study of treatment for Schizophrenia.

A new study to investigate the development of targeted treatments for cognitive impairment in Schizophrenia has been launched today.


Clinical Trials – Trial to prevent COVID-19 begins.

Health experts in New Mexico are working on research to treat and prevent COVID-19.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.